News & Media

Stay in the know
Research News

TP73, an important gene in Adult T-cell Leukemia/Lymphoma

26 October 2022

Adult T-cell leukemia/lymphoma (ATL) is a genetically complex form of blood cancer. In this study led by A/Prof Takaomi ...

Read More →
Research News

A promising new drug delivery system for cancer

26 October 2022

The leakage of chemotherapeutic drugs into tissues other than the tumour can result in adverse side effects. Efforts hav...

Read More →
Research News

A step towards the ambition of precision oncology in recurrent ovarian cancer

26 October 2022

Platinum resistance is a major contributor to ovarian cancer mortality and presents a considerable clinical challenge, n...

Read More →
News

N2CR members conduct liver transplant for stage 4 cancer patient

5 October 2022

2 N2CR members, A/Prof Glenn Bonney and Dr. Raghav Sundar were part of the surgical team who conducted a living donor li...

Read More →
News

Joint ncRNA Symposium and Liquid Biopsy Summit 2022

4 October 2022

  N2CR had the privilege of helping to host the Joint NUS ncRNA Symposium and Liquid Biopsy Summit from 20 – ...

Read More →
Research News

Novel therapy for cancers with aberrant STAT3 activation

5 September 2022

Aberrant activation of the transcription factor, STAT3, can promote cancer progression and occurs in various cancer type...

Read More →
Research News

Black cardamom extract kills lung cancer cells

5 September 2022

Black cardamom (A. subulatum), a commonly used spice, is also used in traditional medicine as a component of ayurvedic f...

Read More →
Research News

New drug as potential therapeutic for Asian patients with advanced Cancer

1 June 2022

The drug Selinexor blocks specific protein that has been shown to be overexpressed in many types of cancer. Authors in t...

Read More →
Research News

A new protein as a target for cancer treatment

1 June 2022

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by ...

Read More →